{"id":5162,"date":"2020-11-18T09:40:10","date_gmt":"2020-11-18T09:40:10","guid":{"rendered":"https:\/\/www.iris-eng.com\/project-single\/rossini\/"},"modified":"2024-10-21T13:53:54","modified_gmt":"2024-10-21T11:53:54","slug":"rossini","status":"publish","type":"project-single","link":"https:\/\/www.iris-eng.com\/de\/project-single\/rossini\/","title":{"rendered":"ETERNAL: Innovating Sustainable Pharmaceutical Processes with Digital Twin Technology"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>In ETERNAL project, IRIS Technology has worked on the development of multi-agent based Digital Twins to reduce the number of experiments done at lab-scale or smaller scale for three case studies (membrane concentration process from AstraZeneca, encapsulation process from Reig Jofr\u00e9 and nitration process from Quotient Sciences). The digitalization of pharmaceutical process increases sustainability by reducing the number of experiments done at early stages, facilitates the API synthesis process scale-up and enables analysing targeted parameters in real-time without the need of offline analysis.<\/p>\n","protected":false},"featured_media":9833,"template":"","class_list":["post-5162","project-single","type-project-single","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.iris-eng.com\/de\/wp-json\/wp\/v2\/project-single\/5162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iris-eng.com\/de\/wp-json\/wp\/v2\/project-single"}],"about":[{"href":"https:\/\/www.iris-eng.com\/de\/wp-json\/wp\/v2\/types\/project-single"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iris-eng.com\/de\/wp-json\/wp\/v2\/media\/9833"}],"wp:attachment":[{"href":"https:\/\/www.iris-eng.com\/de\/wp-json\/wp\/v2\/media?parent=5162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}